US Drug Approval A062055

Erythromycin Ethylsuccinate  Nov 2, 2018

3 approved drug products.
Erythromycin Ethylsuccinate
  • Ingredients: Erythromycin Ethylsuccinate;
  • Dosage form: granule;
  • Route of administration: oral;
  • Strength: eq 200mg base/5ml;
  • Approval date: prior to January 1, 1982;
  • Marketing status: prescription.
Erythromycin Ethylsuccinate
  • Ingredients: Erythromycin Ethylsuccinate;
  • Dosage form: granule;
  • Route of administration: oral;
  • Strength: eq 200mg base/5ml;
  • Approval date: November 2, 2018;
  • Marketing status: prescription.
Erythromycin Ethylsuccinate
  • Ingredients: Erythromycin Ethylsuccinate;
  • Dosage form: granule;
  • Route of administration: oral;
  • Strength: eq 400mg base/5ml;
  • Approval date: November 2, 2018;
  • Marketing status: prescription.

Parties

Applicants
Countries
US

JSON preview

Similar records

Title

Source:  FDA Last updated:  Jul 8, 2019

From the Orange Book, a publication of the U.S. Food and Drug Administration. This record may not reflect the most current and accurate biomedical/scientific data available from the FDA.